Techniques, products, applications, end-users, and geography are all used to segment the Global In-Vitro Diagnostis (IVD) market. However, given the size and complexity of this market, segment overlaps and connections across segments are sure to occur. An overall understanding of inter-segment relationships and intra-segment breakdowns are required to navigate the diagnostic market landscape effectively; this is especially important when marketing segmentation across diagnostic companies is not standardised, and inter-segment subcategories are frequently grouped.
- Global IVD Market Segmentation
The market for IVDs is often segmented, as shown in the points below. Although the segment subcategories given are not complete, they provide a broad sense of the market's complexity. Technique and application are two of the most common market segmentation methods used by diagnostics firms. Market segmentation of Global In-Vitro Diagnostis by goods and end-users is also prevalent; however, most businesses focus on just one subcategory within these sectors. For example, within the end-user industry, some firms specialise solely in point-of-care (POC) goods and hence do not consider segmenting the market by end-users to be helpful.
Market segmentation by techniques is categorised based on the foundational biology and chemistry supporting the diagnostic assay:
Immunoassay
Antibodies are used to target and detect the presence of tiny molecules in a sample.
Haematology
Blood and its components are studied and diagnosed. (haemoglobin, blood proteins, bone marrow, platelets, coagulation factors)
Clinical Chemistry
Chemical components (basic metabolic panel) and proteins (complete metabolic panel) are analysed in body fluids (usually blood or urine).
Molecular Diagnostics
Identification of genetic material or a protein linked to a particular health problem.
Microbiology
Microorganisms such as bacteria, fungus, parasites, and viruses are studied.
In the figure above, coagulation is mentioned as a method; nevertheless, it is frequently used as an application for other procedures (i.e. haematology)
- Techniques and Applications Relationship
A higher-level study of this relationship is necessary because of the tight and intertwined linkages between market tactics and applications. The table below shows the practical uses of each approach in the Global In-Vitro Diagnostis market; In contrast, some techniques may be used for unlisted applications, an unlisted application indicates that it isn't the technique's primary usage and that another approach dominates that
application.
Depending on their particular focus or the magnitude of the disease, diagnostic companies or reports may distinguish certain types of infectious disease as their category; for example, HIV/AIDS (HIV is the virus that causes the AIDS contagious disease) is distinct in the table above to highlight its primary use of immunology and molecular Diagnostic techniques. Immunology is the most commonly used method, and molecular diagnostics is one of the fastest-growing; infectious illnesses are the most comprehensive in 2 of the applications.
- Techniques and Applications Relationship
A higher-level study of this relationship is necessary because of the tight and intertwined linkages between market tactics and applications. The table below shows the practical uses of each approach in the Global In-Vitro Diagnostis market; In contrast, some techniques may be used for unlisted applications, an unlisted application indicates that it isn't the technique's primary usage and that another approach dominates that application.
Depending on their particular focus or the magnitude of the disease, diagnostic companies or reports may distinguish certain types of infectious disease as their category; for example, HIV/AIDS (HIV is the virus that causes the AIDS contagious disease) is distinct in the table above to highlight its primary use of immunology and molecular Diagnostic techniques. Immunology is the most commonly used method, and molecular diagnostics is one of the fastest-growing; infectious illnesses are the most comprehensive in 2 of the applications.
- Immunology The enzyme-linked immunosorbent assay is the most frequent form of immunoassay (ELISA). When a target protein specific to a condition is found in a sample, this approach employs fluorescently attached antibodies to provide a visual signal. This is the most widely used technology in central lab diagnostics, accounting for around 40% of the market. All pregnancy tests, which account for about 90% of the patient self-testing market, are based on antibody detection.
- Molecular Diagnostics Lab-on-a-chip (LOC), real-time polymerase chain reaction (RT-PCR) & multiplexing, and next-generation sequencing are the three primary promising technologies in molecular diagnostics (NGS).
- Viruses and Infectious Diseases
As previously said, the infectious disease application covers a broad spectrum of ailments. It is frequently split down or regrouped depending on the message a firm or report is attempting to communicate. The prevalence of some of the most prevalent infectious illnesses is seen in the graph below. Flu, meningitis, pneumonia, TB, and RSV are among the more frequent contagious diseases.
Indeed, there is significant connectivity across Global In-Vitro Diagnostis markets by method and application and goods, end-users, and region; for example, a North American diagnostic laboratory may contain an immunoassay instrument system that performs several applications. Visit the Global Monitor Website to read the detailed report.
0 Comments